Latest News and Press Releases

* First half profit of DKK 521m before tax . best ever * Growth in lending still at a high level * Total lending of just under DKK 235bn * Market shares continue to increase * Income/cost...

* Halvårsresultat 521 mio. kr. før skat . bedste nogensinde * Fortsat høj udlånsvækst * Samlet udlån knapt 235 mia. kr. * Markedsandele øges fortsat * Indtjeningen pr. omkostningskrone...

The Q2 and H1 2007 interim report of AS Tallinna Vesi is available on the Internet homepage of the Tallinn Stock Exchange at http://www.ee.omxgroup.com/reports ("Listed companies / Financial...

Gunnebo Interim Report January-June 2007 HIGHLIGHTS Second quarter 2007  The order intake declined organically by 3% to MSEK 1,720 (1,784)  Invoiced sales rose organically by 7% to MSEK 1,763...

Gunnebo delårsrapport januari-juni 2007 SAMMANFATTNING Andra kvartalet 2007  Orderingången minskade organiskt med 3% till 1 720 Mkr (1 784)  Faktureringen ökade organiskt med 7% till 1 763 Mkr (1...

MANAGEMENT REPORT RESULTS OF OPERATIONS - FOR THE 2nd QUARTER 2007, EUR Overview ...

MANAGEMENT REPORT RESULTS OF OPERATIONS - FOR THE 2nd QUARTER 2007, EEK Overview ...

Dear investors and specialists of the financial field, We are kindly inviting You to come to pharmaceutical company Sanitas AB conference „Review of the results of the first half of the year, 2007...

DUBLIN, IRELAND--(Marketwire - July 19, 2007) - Alltracel releases 2007 AGM update - Solid trading and continued technology and commercial breakthroughs - - NanopeuticsTM...

DUBLIN, IRELAND--(Marketwire - July 19, 2007) - Alltracel Announces a NanopeuticsTM Product and Technology Development License Agreement with HemCon Medical Technologies to Serve the Military...